Progression of familial and non-familial dilated cardiomyopathy: Long term follow up

Heart

Volumn 89, Issue 7, 2003, Pages 757-761

  Michels, Virginia V ^a   Driscoll, D J ^a   Miller, F A ^a   Olson, T M ^a   Atkinson, E J ^a   Olswold, C L ^a   Schaid, D J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; FAMILIAL DISEASE; FAMILY STUDY; FOLLOW UP; HEALTH STATUS; HEART DILATATION; HEART TRANSPLANTATION; HUMAN; LONG TERM CARE; MALE; MEDICAL RECORD; MORTALITY; POSTAL MAIL; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

EID: 0038037680     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.89.7.757     Document Type: Article

References (28)

1. Johnson RA, Palacios I. Dilated cardiomyopathies of the adult (first of two parts). N Engl J Med 1982;307:1051-8.
2. Michels VV, Moll PP, Miller FA, et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 1992;326:77-82.
3. Grunig E, Tasman JA, Kucherer H, et al. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 1998;31:186-94.
4. Keeling PJ, Gang Y, Smith G, et al. Familial dilated cardiomyopathy in the United Kingdom. BMJ 1995;73:417-21.
5. Olson TM, Michels VV, Thibodeau SN, et al. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998;280:750-2.
6. Kamisago M, Sharma SD, DePalma SR, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 2000;343:1688-96.
7. Olson TM, Kishimoto NY, Whitby FG, et al. Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol 2001;33:723-32.
8. Fatkin D, MacRae C, Sasaki T, et al. Missense mutations in the rod domain of the lamin a/c gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 1999;341:1715-24.
9. Tsubata S, Bowles KR, Vatta M, et al. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 2000;106:655-62.
10. Schönberger J, Seidman CE. Many roads lead to a broken heart: the genetics of dilated cardiomyopathy. Am J Hum Genet 2001;69:249-60.
11. Bahler RC. Assessment of prognosis in idiopathic dilated cardiomyopathy. Chest 2002;121:1016-19.
12. Mestroni L, Rocco C, Gregori D, et al. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart muscle disease study group. J Am Coll Cardiol 1999;34:181-90.
13. Valantine HA, Hunt SA, Fowler MB, et al. Frequency of familial nature of dilated cardiomyopathy and usefulness of cardiac transplantation in this subset. Am J Cardiol 1989;63:959-63.
14. Diaz RA, Obasohan A, Oakley CM. Prediction of outcome in dilated cardiomyopathy. Br Heart J 1987;58:393-9.
15. Crispell KA, Wray A, Ni H, et al. Clinical profiles of four large pedigrees with familial dilated cardiomyopathy. J Am Coll Cardiol 1999;34:837-47.
16. Michels VV, Olso TM, Miller FM, et al. Frequency of development of idiopathic dilated cardiomyopathy among relatives of patients with idiopathic dilated cardiomyopathy Am J Cardiol (in press).
17. Michels VV, Tazelaar HD, Driscoll DJ, et al. Histopathology of familial versus nonfamilial dilated cardiomyopathy. Cardiovasc Pathol 1993;2:219-23.
18. Michels VV, Moll PP, Rodeheffer RJ, et al. Circulating heart autoantibodies in familial as compared with nonfamilial idiopathic dilated cardiomyopathy. Mayo Clin Proc 1994;69:24-7.
19. Goerss JB, Michels VV, Burnett J, et al. Frequency of familial dilated cardiomyopathy. Eur Heart J 1995;16(suppl 0):2-4.
20. Csanȧdy M, Högye M, Kallai A, et al. Familial dilated cardiomyopathy: a worse prognosis compared with sporadic forms. Br Heart J 1995;74:171-3.
21. Abraham WT, Bristow MR. Specialized centers for heart failure management. Circulation 1997;96:2755-7.
22. Lapu-Bula R, Robert A, De Kock M, et al. Risk stratification in patients with dilated cardiomyopathy: contribution of Doppler-derived left ventricular filling. Am J Cardiol 1998;82:779-85.
23. Alla F, Briancon S, Juilliere Y, et al. Differential clinical prognostic classifications in dilated and ischemic advanced heart failure: the EPICAL study. Am Heart J 2000;139:895-904.
24. Kawai K, Takaoka H, Hata K, et al. Prevalence, predictors, and prognosis of reversal of maladaptive remodeling with intensive medical therapy in idiopathic dilated cardiomyopathy. Am J Cardiol 1999;84:671-6.
25. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342:1077-84.
26. Pinamonti B, Zecchin M, Di Lenarda A, et al. Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. J Am Coll Cardiol 1997;29:604-12.
27. Yi G, Goldman JH, Keeling PJ, et al. Heart rate variability in idiopathic dilated cardiomyopathy: relation to disease severity and prognosis. Heart 1997;77:108-14.
28. Schmidt MA, Michels VV, Edwards WD, et al. Familial dilated cardiomyopathy. Am J Med Genet 1988;31:135-43.